Clinical Trial Update: Erythromycin Versus Azithromycin in Preterm Premature Rupture of Membranes [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing erythromycin and azithromycin for preterm premature rupture of membranes was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preterm Premature Rupture of Membranes

Drugs mentioned

• Azithromycin (azithromycin)
• ERYTHROMYCIN (ERYTHROMYCIN)

Snippet

Sponsor: Indiana University | Conditions: Preterm Premature Ruptured Membranes | Phase 3 | Status: WITHDRAWN